An open, single-centre, controlled trial to investigate the efficacy and usability of published best practice to control glycaemia in hospitalised patients with type 2 diabetes.

Trial Profile

An open, single-centre, controlled trial to investigate the efficacy and usability of published best practice to control glycaemia in hospitalised patients with type 2 diabetes.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Dec 2013

At a glance

  • Drugs Insulin aspart (Primary) ; Insulin glargine (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Apr 2012 Planned end date changed from 19 Dec 2011 to 1 Apr 2012 as reported by ClinicalTrials.gov.
    • 29 Jul 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
    • 29 Jul 2011 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top